Product/Composition:- | Azacitidine |
---|---|
Strength:- | 100 mg/vial |
Form:- | Injectable |
Reference Brands:- | Vidaza®(EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Azacitidine 50 mg and 100 mg Vials (brand name Vidaza®) are used in oncology to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). As a hypomethylating agent, Azacitidine works by inhibiting DNA methylation, promoting the reactivation of genes that control blood cell growth. Available as subcutaneous or intravenous injections, it is vital for patients who are ineligible for intensive chemotherapy.
Azacitidine 50 mg and 100 mg Vials are essential treatments for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Available under the brand name Vidaza®, Azacitidine is a hypomethylating agent that plays a critical role in restoring normal blood cell production in patients with MDS or AML. It works by inhibiting DNA methylation, leading to the reactivation of growth-controlling genes. Azacitidine is available in subcutaneous and intravenous injection forms in 50 mg and 100 mg vials, and is crucial in oncology B2B portfolios focused on blood cancers and hematologic malignancies.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications